These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21556248)

  • 1. Quality of life and neutropenia in patients with early stage breast cancer: a randomized pilot study comparing additional treatment with mistletoe extract to chemotherapy alone.
    Tröger W; Jezdić S; Zdrale Z; Tišma N; Hamre HJ; Matijašević M
    Breast Cancer (Auckl); 2009 Jul; 3():35-45. PubMed ID: 21556248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial.
    Tröger W; Zdrale Z; Tišma N; Matijašević M
    Evid Based Complement Alternat Med; 2014; 2014():430518. PubMed ID: 24701238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolerability].
    Loewe-Mesch A; Kuehn JJ; Borho K; Abel U; Bauer C; Gerhard I; Schneeweiss A; Sohn C; Strowitzki T; v Hagens C
    Forsch Komplementmed; 2008 Feb; 15(1):22-30. PubMed ID: 18334811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone.
    Tröger W; Zdrale Z; Stanković N; Matijašević M
    Breast Cancer (Auckl); 2012; 6():173-80. PubMed ID: 23150723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study.
    Kim KC; Yook JH; Eisenbraun J; Kim BS; Huber R
    BMC Complement Altern Med; 2012 Oct; 12():172. PubMed ID: 23033982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients.
    Biswal BM; Sulaiman SA; Ismail HC; Zakaria H; Musa KI
    Integr Cancer Ther; 2013 Jul; 12(4):312-22. PubMed ID: 23142798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
    Osoba D; Zee B; Pater J; Warr D; Kaizer L; Latreille J
    Qual Life Res; 1994 Oct; 3(5):353-64. PubMed ID: 7841968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial.
    Tröger W; Galun D; Reif M; Schumann A; Stanković N; Milićević M
    Dtsch Arztebl Int; 2014 Jul; 111(29-30):493-502, 33 p following 502. PubMed ID: 25142075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the mistletoe and breast cancer (MAB) trial: a protocol for a randomised double-blind controlled trial.
    Bryant S; Duncan L; Feder G; Huntley AL
    Pilot Feasibility Stud; 2022 Apr; 8(1):78. PubMed ID: 35387677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mistletoe therapy in oncology.
    Horneber MA; Bueschel G; Huber R; Linde K; Rostock M
    Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD003297. PubMed ID: 18425885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
    Iwase S; Kawaguchi T; Yotsumoto D; Doi T; Miyara K; Odagiri H; Kitamura K; Ariyoshi K; Miyaji T; Ishiki H; Inoue K; Tsutsumi C; Sagara Y; Yamaguchi T
    Support Care Cancer; 2016 Feb; 24(2):637-646. PubMed ID: 26105516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.